Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/ Raxibacumab-Treated New Zealand White Rabbits by Cecil Chen, Chris Ward, Michele Fiscella, Sally Bolmer, Thi-Sau Migone, Alfred Corey, Gabriel Meister

Subjects: Get full text

Approval of raxibacumab for the treatment of inhalation anthrax under the US Food and Drug Administration Animal rule by Chia-Wei eTsai, Stephen eMorris

Subjects: Get full text

Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults by Katherine A. Hendricks, Mary E. Wright, Sean V. Shadomy, John S. Bradley, Meredith G. Morrow, Andy T. Pavia, Ethan Rubinstein, Jon-Erik C. Holty, Nancy E. Messonnier, Theresa L. Smith, Nicki Pesik, Tracee A. Treadwell, William A. Bower

Subjects: Get full text

Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax by Bruce Huang, Tao Xie, David Rotstein, Hui Fang, David M. Frucht

Subjects: Get full text